Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis-Reference-Cited by-同舟云学术

Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis

Published:2016-09 Issue:9 Volume:107 Page:1263-1269
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Terashima Takeshi¹²,Yamashita Tatsuya²,Arai Kuniaki¹,Kawaguchi Kazunori¹,Kitamura Kazuya²,Yamashita Taro²,Sakai Yoshio¹,Mizukoshi Eishiro¹,Honda Masao¹,Kaneko Shuichi¹

Affiliation:

1. Faculty of Medicine Institute of Medical Pharmaceutical and Health Sciences Kanazawa University Kanazawa Japan

2. Department of Gastroenterology Kanazawa University Hospital Kanazawa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12992

Reference25 articles.

1. Diagnosis of Hepatocellular Carcinoma: Newer Radiological Tools

2. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma

3. Randomized, Phase II Study Comparing Interferon Combined with Hepatic Arterial Infusion of Fluorouracil plus Cisplatin and Fluorouracil Alone in Patients with Advanced Hepatocellular Carcinoma

4. Sorafenib in Advanced Hepatocellular Carcinoma

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma;BMC Cancer;2024-05-14

2. Conversion therapy for initially unresectable hepatocellular carcinoma: Current status and prospects;BioScience Trends;2023-12-31

3. Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child–Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial;BMC Cancer;2022-04-09

4. Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment;Liver Cancer;2022

5. Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort Study;Oncology;2022